# Daily Journal Corp: financial statements, quarterly

DJCO · Nasdaq · CIK 783412 · [Communication](/sectors/communication.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/djco.md) · [Financials](/companies/djco/financials.md) · [Filings](/companies/djco/filings.md) · [Insiders](/companies/djco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/djco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.6 d](/filings/0001437749-24-038552.md) | [16.0](/filings/0001437749-25-004279.md) | [16.6](/filings/0001437749-25-017831.md) | [17.5](/filings/0001437749-25-026968.md) | [19.9 d](/filings/0001437749-25-038836.md) | [17.7](/filings/0001437749-26-004226.md) | [18.2](/filings/0001437749-26-017059.md) | [23.4](/filings/0001437749-26-027344.md) | [28.4 d](/filings/0001437749-25-038836.md) | [19.5](/filings/0001437749-26-004226.md) | [22.7](/filings/0001437749-26-017059.md) | [27.0](/filings/0001437749-26-027344.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [3.4 d](/filings/0001437749-24-038552.md) | [0.6](/filings/0001437749-25-004279.md) | [0.6](/filings/0001437749-25-017831.md) | [1.1](/filings/0001437749-25-026968.md) | [1.7 d](/filings/0001437749-25-038836.md) | [0.7](/filings/0001437749-26-004226.md) | [1.0](/filings/0001437749-26-017059.md) | [3.2](/filings/0001437749-26-027344.md) | [4.6 d](/filings/0001437749-25-038836.md) | [0.5](/filings/0001437749-26-004226.md) | [3.0](/filings/0001437749-26-017059.md) | [5.3](/filings/0001437749-26-027344.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(3.0) d](/filings/0001437749-24-038552.md) | [3.1](/filings/0001437749-25-004279.md) | [5.2](/filings/0001437749-25-017831.md) | [8.5](/filings/0001437749-25-026968.md) | [9.4 d](/filings/0001437749-25-038836.md) | [4.0](/filings/0001437749-26-004226.md) | [16.6](/filings/0001437749-26-017059.md) | [3.8](/filings/0001437749-26-027344.md) | [13.5 d](/filings/0001437749-25-038836.md) | [(2.1)](/filings/0001437749-26-004226.md) | [(12.4)](/filings/0001437749-26-017059.md) | [(5.1)](/filings/0001437749-26-027344.md) |
| Net income | $m | [(6.5) d](/filings/0001437749-24-038552.md) | [12.6](/filings/0001437749-25-026968.md) | [15.4](/filings/0001437749-25-026968.md) | [23.4](/filings/0001437749-25-026968.md) | [26.7 d](/filings/0001437749-25-038836.md) | [10.9](/filings/0001437749-26-027344.md) | [44.7](/filings/0001437749-26-027344.md) | [14.4](/filings/0001437749-26-027344.md) | [42.2 d](/filings/0001437749-25-038836.md) | [(8.0)](/filings/0001437749-26-027344.md) | [(34.6)](/filings/0001437749-26-027344.md) | [(10.9)](/filings/0001437749-26-027344.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | [7.91](/filings/0001437749-26-004226.md) | [32.43](/filings/0001437749-26-017059.md) | [10.47](/filings/0001437749-26-027344.md) | not reported | [(5.79)](/filings/0001437749-26-004226.md) | [(25.14)](/filings/0001437749-26-017059.md) | [(7.90)](/filings/0001437749-26-027344.md) |
| Basic EPS | $ per share | not reported | [9.16](/filings/0001437749-25-004279.md) | [11.19](/filings/0001437749-25-017831.md) | [16.96](/filings/0001437749-25-026968.md) | not reported | [7.91](/filings/0001437749-26-004226.md) | [32.43](/filings/0001437749-26-017059.md) | [10.47](/filings/0001437749-26-027344.md) | not reported | [(5.79)](/filings/0001437749-26-004226.md) | [(25.14)](/filings/0001437749-26-017059.md) | [(7.90)](/filings/0001437749-26-027344.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.8](/filings/0001437749-25-038836.md) | [14.4](/filings/0001437749-24-004225.md) | [10.6](/filings/0001437749-24-016729.md) | [10.0](/filings/0001437749-24-026890.md) | [13.0](/filings/0001437749-26-027344.md) | [15.0](/filings/0001437749-25-004279.md) | [11.8](/filings/0001437749-25-017831.md) | [18.7](/filings/0001437749-25-026968.md) | [20.6](/filings/0001437749-26-027344.md) | [16.6](/filings/0001437749-26-004226.md) | [20.6](/filings/0001437749-26-017059.md) | [31.1](/filings/0001437749-26-027344.md) |
| Current assets | $m | [345](/filings/0001437749-24-038552.md) | [348](/filings/0001437749-24-004225.md) | [326](/filings/0001437749-24-016729.md) | [361](/filings/0001437749-24-026890.md) | [394](/filings/0001437749-25-038836.md) | [403](/filings/0001437749-25-004279.md) | [459](/filings/0001437749-25-017831.md) | [486](/filings/0001437749-25-026968.md) | [538](/filings/0001437749-26-027344.md) | [518](/filings/0001437749-26-004226.md) | [472](/filings/0001437749-26-017059.md) | [464](/filings/0001437749-26-027344.md) |
| Total assets | $m | [355](/filings/0001437749-24-038552.md) | [357](/filings/0001437749-25-004279.md) | [336](/filings/0001437749-25-017831.md) | [370](/filings/0001437749-25-026968.md) | [404](/filings/0001437749-25-038836.md) | [413](/filings/0001437749-25-004279.md) | [468](/filings/0001437749-25-017831.md) | [495](/filings/0001437749-25-026968.md) | [548](/filings/0001437749-26-027344.md) | [529](/filings/0001437749-26-004226.md) | [480](/filings/0001437749-26-017059.md) | [472](/filings/0001437749-26-027344.md) |
| Current liabilities | $m | [42.2](/filings/0001437749-24-038552.md) | [34.7](/filings/0001437749-24-004225.md) | [36.4](/filings/0001437749-24-016729.md) | [42.0](/filings/0001437749-24-026890.md) | [38.4](/filings/0001437749-25-038836.md) | [32.8](/filings/0001437749-25-004279.md) | [30.3](/filings/0001437749-25-017831.md) | [39.1](/filings/0001437749-25-026968.md) | [38.8](/filings/0001437749-26-027344.md) | [31.8](/filings/0001437749-26-004226.md) | [30.6](/filings/0001437749-26-017059.md) | [39.8](/filings/0001437749-26-027344.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [125](/filings/0001437749-25-038836.md) | not reported | not reported | not reported | [157](/filings/0001437749-26-027344.md) | [146](/filings/0001437749-26-004226.md) | [131](/filings/0001437749-26-017059.md) | [134](/filings/0001437749-26-027344.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [200](/filings/0001437749-25-038836.md) | [213](/filings/0001437749-25-026968.md) | [228](/filings/0001437749-25-026968.md) | [252](/filings/0001437749-25-026968.md) | [279](/filings/0001437749-26-027344.md) | [290](/filings/0001437749-26-027344.md) | [334](/filings/0001437749-26-027344.md) | [349](/filings/0001437749-26-027344.md) | [391](/filings/0001437749-26-027344.md) | [383](/filings/0001437749-26-027344.md) | [349](/filings/0001437749-26-027344.md) | [338](/filings/0001437749-26-027344.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.7 d](/filings/0001437749-24-038552.md) | [(1.2)](/filings/0001437749-25-004279.md) | [(3.7) d](/filings/0001437749-25-017831.md) | [1.6 d](/filings/0001437749-25-026968.md) | [3.1 d](/filings/0001437749-25-038836.md) | [2.2](/filings/0001437749-26-004226.md) | [(0.6) d](/filings/0001437749-26-017059.md) | [7.2 d](/filings/0001437749-26-027344.md) | [4.5 d](/filings/0001437749-25-038836.md) | [(1.9)](/filings/0001437749-26-004226.md) | [4.1 d](/filings/0001437749-26-017059.md) | [10.8 d](/filings/0001437749-26-027344.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001437749-24-038552.md) | [0.0](/filings/0001437749-25-004279.md) | [0.0](/filings/0001437749-25-017831.md) | [(0.0) d](/filings/0001437749-25-026968.md) | [0.0 d](/filings/0001437749-25-038836.md) | [0.0](/filings/0001437749-26-004226.md) | [0.0 d](/filings/0001437749-26-017059.md) | [0.0 d](/filings/0001437749-26-027344.md) | [0.0 d](/filings/0001437749-25-038836.md) | [0.0](/filings/0001437749-26-004226.md) | [0.0 d](/filings/0001437749-26-017059.md) | [0.1 d](/filings/0001437749-26-027344.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,377](/filings/0001437749-26-004226.md) | [1,377](/filings/0001437749-26-017059.md) | [1,377](/filings/0001437749-26-027344.md) | [1,378](/filings/0001437749-26-004226.md) | [1,378](/filings/0001437749-26-017059.md) | [1,378](/filings/0001437749-26-027344.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,377,952 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001437749-26-027344.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.